Chairperson: V. van Hinsbergh (Amsterdam, NL)
| (K201) | Lymphangiogenesis. |
| K. Alitalo, and collaborators (Helsinki, FI) | |
| (K202) | Anti-angiogenesis: Preclinical and clinical development. |
| N. Ferrara (San Francisco CA, US) | |
| (O203) | Shp-2 is involved in bFGF dependent endothelial cell proliferation and prevents apoptosis. |
| H. Bridell, Chr. Plank, T. Gloe, N. Hellwig, H-Y. Sohn, U. Pohl, F. Krötz (München, DE) | |
| (O204) | FrzA/sFRP-1 activates non canonical Wnt signaling pathway in endothelial cells through interaction with Frizzled 4, 6 and 7. |
| J. Ezan, P. Dufourcq, C. Moreau, T. Couffinhal, C. Duplaa (Pessac and Bordeaux, FR) |